This review outlines the molecular and metabolic differences between adaptive and maladaptive right ventricular hypertrophy in pulmonary arterial hypertension, identifying novel therapeutic targets for restoring RV function.
No takes yet. Share an insight, caveat, or question.
Supports RV-targeted therapies in PAH; leaves open clinical translation of experimental restoration.
Ryan et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: